US Stock MarketDetailed Quotes

Cellectar BioSciences (CLRB)

Watchlist
  • 2.760
  • -0.060-2.13%
Close Apr 10 16:00 ET
  • 2.760
  • 0.0000.00%
Post 20:01 ET
11.70MMarket Cap-0.33P/E (TTM)

Cellectar BioSciences (CLRB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.41%-23.12M
60.19%-4.34M
53.36%-4.28M
63.82%-5.12M
29.77%-9.38M
-46.97%-47.58M
-13.73%-10.91M
-13.62%-9.17M
-87.80%-14.14M
-86.00%-13.36M
Net income from continuing operations
51.12%-21.79M
-124.81%-5.3M
69.70%-4.44M
-492.57%-5.45M
75.21%-6.6M
-4.23%-44.58M
70.11%-2.36M
16.30%-14.66M
90.97%-919.37K
-270.52%-26.64M
Operating gains losses
87.24%-753.71K
97.04%-297.83K
-117.78%-294.28K
95.97%-501.6K
-97.73%340K
-238.72%-5.91M
-125.30%-10.07M
-79.71%1.65M
-736.32%-12.46M
1,175.67%14.96M
Depreciation and amortization
-26.76%213.6K
-27.87%49.46K
-23.76%52.28K
-15.84%55.56K
-36.38%56.3K
51.61%291.65K
-1.99%68.57K
66.40%68.57K
70.82%66.02K
107.93%88.49K
Other non cash items
16.50%76.2K
16.64%20.17K
16.56%19.41K
----
----
12.68%65.41K
13.15%17.29K
13.00%16.65K
----
----
Change In working capital
-81.20%-3.13M
1,062.01%611.5K
-107.93%-176.44K
110.61%176.4K
-68.18%-3.74M
-149.65%-1.73M
-104.01%-63.57K
200.23%2.22M
-910.94%-1.66M
-334.77%-2.22M
-Change in prepaid assets
262.35%119.23K
-66.63%224.98K
27.09%509.17K
15.76%-589.08K
94.25%-25.83K
57.68%-73.44K
186.58%674.15K
160.08%400.64K
-193.65%-699.27K
8.14%-448.96K
-Change in payables and accrued expense
-98.44%-3.16M
156.87%408.87K
-136.07%-664.03K
186.41%804.28K
-107.93%-3.71M
-143.06%-1.59M
-152.71%-718.97K
29.39%1.84M
-81.48%-930.74K
-225.14%-1.78M
-Change in other current liabilities
-43.13%-84.42K
-19.18%-22.34K
-19.19%-21.58K
-19.17%-20.84K
-323.67%-19.65K
-16.00%-58.98K
-16.94%-18.75K
-16.94%-18.11K
-16.94%-17.49K
-5.96%-4.64K
-Change in other working capital
----
----
----
----
16.34%17.96K
----
----
----
----
11.62%15.44K
Cash from discontinued investing activities
Operating cash flow
51.41%-23.12M
60.19%-4.34M
53.36%-4.28M
63.82%-5.12M
29.77%-9.38M
-46.97%-47.58M
-13.73%-10.91M
-13.62%-9.17M
-87.80%-14.14M
-86.00%-13.36M
Investing cash flow
Cash flow from continuing investing activities
94.36%-5.88K
90.41%-5.88K
0
0
0
87.94%-104.2K
77.03%-61.29K
0
-21.28K
-21.63K
Net PPE purchase and sale
94.36%-5.88K
90.41%-5.88K
--0
--0
--0
87.94%-104.2K
77.03%-61.29K
--0
---21.28K
---21.63K
Cash from discontinued investing activities
Investing cash flow
94.36%-5.88K
90.41%-5.88K
--0
--0
--0
87.94%-104.2K
77.03%-61.29K
--0
---21.28K
---21.63K
Financing cash flow
Cash flow from continuing financing activities
-78.78%13.03M
4.99M
-67.04%5.79M
225,137,900.00%2.25M
0
167.71%61.41M
0
-21.94%17.56M
1
1,461,648,800.00%43.85M
Net common stock issuance
--5.79M
--0
----
----
----
--0
--0
----
----
----
Net preferred stock issuance
----
----
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
-88.21%7.24M
--4.99M
-100.00%3
225,137,900.00%2.25M
--0
7,677.05%61.41M
--0
4,937.13%17.56M
--1
1,461,648,800.00%43.85M
Cash from discontinued financing activities
Financing cash flow
-78.78%13.03M
--4.99M
-67.04%5.79M
225,137,900.00%2.25M
--0
167.71%61.41M
--0
-21.94%17.56M
--1
1,461,648,800.00%43.85M
Net cash flow
Beginning cash position
143.48%23.29M
-63.36%12.55M
-57.32%11.04M
-65.26%13.91M
143.48%23.29M
-51.85%9.56M
80.46%34.26M
402.02%25.87M
215.64%40.03M
-51.85%9.56M
Current changes in cash
-173.54%-10.09M
105.85%641.74K
-81.97%1.51M
79.78%-2.86M
-130.80%-9.38M
233.22%13.72M
-16.49%-10.97M
-39.32%8.39M
-88.09%-14.16M
524.10%30.47M
End cash Position
-43.34%13.2M
-43.34%13.2M
-63.36%12.55M
-57.32%11.04M
-65.26%13.91M
143.48%23.29M
143.48%23.29M
80.46%34.26M
402.02%25.87M
215.64%40.03M
Free cash flow
51.51%-23.12M
60.36%-4.35M
53.36%-4.28M
63.88%-5.12M
29.89%-9.38M
-43.46%-47.69M
-11.28%-10.97M
-5.79%-9.17M
-88.09%-14.16M
-86.30%-13.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.41%-23.12M60.19%-4.34M53.36%-4.28M63.82%-5.12M29.77%-9.38M-46.97%-47.58M-13.73%-10.91M-13.62%-9.17M-87.80%-14.14M-86.00%-13.36M
Net income from continuing operations 51.12%-21.79M-124.81%-5.3M69.70%-4.44M-492.57%-5.45M75.21%-6.6M-4.23%-44.58M70.11%-2.36M16.30%-14.66M90.97%-919.37K-270.52%-26.64M
Operating gains losses 87.24%-753.71K97.04%-297.83K-117.78%-294.28K95.97%-501.6K-97.73%340K-238.72%-5.91M-125.30%-10.07M-79.71%1.65M-736.32%-12.46M1,175.67%14.96M
Depreciation and amortization -26.76%213.6K-27.87%49.46K-23.76%52.28K-15.84%55.56K-36.38%56.3K51.61%291.65K-1.99%68.57K66.40%68.57K70.82%66.02K107.93%88.49K
Other non cash items 16.50%76.2K16.64%20.17K16.56%19.41K--------12.68%65.41K13.15%17.29K13.00%16.65K--------
Change In working capital -81.20%-3.13M1,062.01%611.5K-107.93%-176.44K110.61%176.4K-68.18%-3.74M-149.65%-1.73M-104.01%-63.57K200.23%2.22M-910.94%-1.66M-334.77%-2.22M
-Change in prepaid assets 262.35%119.23K-66.63%224.98K27.09%509.17K15.76%-589.08K94.25%-25.83K57.68%-73.44K186.58%674.15K160.08%400.64K-193.65%-699.27K8.14%-448.96K
-Change in payables and accrued expense -98.44%-3.16M156.87%408.87K-136.07%-664.03K186.41%804.28K-107.93%-3.71M-143.06%-1.59M-152.71%-718.97K29.39%1.84M-81.48%-930.74K-225.14%-1.78M
-Change in other current liabilities -43.13%-84.42K-19.18%-22.34K-19.19%-21.58K-19.17%-20.84K-323.67%-19.65K-16.00%-58.98K-16.94%-18.75K-16.94%-18.11K-16.94%-17.49K-5.96%-4.64K
-Change in other working capital ----------------16.34%17.96K----------------11.62%15.44K
Cash from discontinued investing activities
Operating cash flow 51.41%-23.12M60.19%-4.34M53.36%-4.28M63.82%-5.12M29.77%-9.38M-46.97%-47.58M-13.73%-10.91M-13.62%-9.17M-87.80%-14.14M-86.00%-13.36M
Investing cash flow
Cash flow from continuing investing activities 94.36%-5.88K90.41%-5.88K00087.94%-104.2K77.03%-61.29K0-21.28K-21.63K
Net PPE purchase and sale 94.36%-5.88K90.41%-5.88K--0--0--087.94%-104.2K77.03%-61.29K--0---21.28K---21.63K
Cash from discontinued investing activities
Investing cash flow 94.36%-5.88K90.41%-5.88K--0--0--087.94%-104.2K77.03%-61.29K--0---21.28K---21.63K
Financing cash flow
Cash flow from continuing financing activities -78.78%13.03M4.99M-67.04%5.79M225,137,900.00%2.25M0167.71%61.41M0-21.94%17.56M11,461,648,800.00%43.85M
Net common stock issuance --5.79M--0--------------0--0------------
Net preferred stock issuance ----------------------0--0------------
Proceeds from stock option exercised by employees -88.21%7.24M--4.99M-100.00%3225,137,900.00%2.25M--07,677.05%61.41M--04,937.13%17.56M--11,461,648,800.00%43.85M
Cash from discontinued financing activities
Financing cash flow -78.78%13.03M--4.99M-67.04%5.79M225,137,900.00%2.25M--0167.71%61.41M--0-21.94%17.56M--11,461,648,800.00%43.85M
Net cash flow
Beginning cash position 143.48%23.29M-63.36%12.55M-57.32%11.04M-65.26%13.91M143.48%23.29M-51.85%9.56M80.46%34.26M402.02%25.87M215.64%40.03M-51.85%9.56M
Current changes in cash -173.54%-10.09M105.85%641.74K-81.97%1.51M79.78%-2.86M-130.80%-9.38M233.22%13.72M-16.49%-10.97M-39.32%8.39M-88.09%-14.16M524.10%30.47M
End cash Position -43.34%13.2M-43.34%13.2M-63.36%12.55M-57.32%11.04M-65.26%13.91M143.48%23.29M143.48%23.29M80.46%34.26M402.02%25.87M215.64%40.03M
Free cash flow 51.51%-23.12M60.36%-4.35M53.36%-4.28M63.88%-5.12M29.89%-9.38M-43.46%-47.69M-11.28%-10.97M-5.79%-9.17M-88.09%-14.16M-86.30%-13.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More